首页> 外文期刊>Therapeutic Drug Monitoring >The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
【24h】

The monitoring of immunosuppressive drugs: a pharmacodynamic approach.

机译:免疫抑制药物的监测:一种药效学方法。

获取原文
获取原文并翻译 | 示例
       

摘要

Pharmacodynamic monitoring measures biologic response to a drug, which, alone or coupled with pharmacokinetics, provides a novel method for the optimization of drug dosing. Pharmacodynamic monitoring has been investigated by us and other investigators on primarily five immunosuppressive drugs: cyclosporine (CsA), mycophenolate mofetil (MMF), rapamycin (RAPA), azathioprine (AZA), and methylprednisolone (MP). The pharmacodynamic monitoring of CsA and MMF involves measurement of the activity of the enzymes calcineurin and inosine monophosphate dehydrogenase, respectively. The pharmacodynamics of AZA are assessed by measurement of the activity of thiopurine methyl transferase (TPMT), which is induced by a metabolite of AZA, 6-mercaptopurine. The pharmacodyamics for RAPA involve the measurement of a P70 S6 kinase activity within lymphocytes, whereas that for MP involves the measurement of the endogenous synthesis of cortisol by the suppression of the hypothalamic pituitary axis. To date, the most detailed studies have been performed involving pharmacodynamic monitoring of CsA and MMF. Similarities exist in the pharmacodynamic response to CsA and MMF in patients who undergo renal transplantation. At trough concentrations in blood, both drugs result in only a 50% reduction in activity of their target enzymes; however, there is considerable interpatient variability. Throughout the dosing interval, enzyme activity parallels that of drug concentrations. Renal transplant recipients who are treated with AZA and who exhibit an increase in TPMT activity from the time of transplantation experience fewer episodes of active rejection. Renal transplant recipients who are administered MP and in whom suppression of endogenous synthesis of cortisol is greatest exhibit the least incidence of steroid-induced side effects. Additional clinical trials relating pharmacokinetics and pharmacodynamic parameters to clinical response are under way to ascertain which provides the best guide for dosing. Pharmacodynamic monitoring may provide an alternative approach to traditional drug level measurement.
机译:药效动力学监测测量对药物的生物反应,单独或与药代动力学结合,可提供一种优化药物剂量的新颖方法。我们和其他研究人员已对药理动力学监测进行了调查,主要针对五种免疫抑制药物:环孢素(CsA),霉酚酸酯(MMF),雷帕霉素(RAPA),硫唑嘌呤(AZA)和甲基强的松龙(MP)。 CsA和MMF的药效学监测分别涉及钙调神经磷酸酶和肌苷单磷酸脱氢酶活性的测量。 AZA的药效学是通过测量硫嘌呤甲基转移酶(TPMT)的活性来评估的,该活性是由AZA的代谢产物6-巯基嘌呤诱导的。 RAPA的药代动力学涉及淋巴细胞内P70 S6激酶活性的测定,而MP的则涉及通过抑制下丘脑垂体轴来测定皮质醇的内源性合成。迄今为止,已进行了涉及CsA和MMF药效动力学监测的最详细的研究。肾移植患者对CsA和MMF的药效学反应相似。在血液中达到谷底浓度时,两种药物都只会使其靶酶的活性降低50%。但是,患者之间存在很大差异。在整个给药间隔中,酶活性与药物浓度平行。从移植之日起,接受AZA治疗并表现出TPMT活性增强的肾移植受者经历的活动性排斥反应较少。接受MP给药且肾上腺皮质醇的内源性合成抑制作用最大的肾移植受者,其类固醇诱导的副作用发生率最低。正在进行有关将药代动力学和药效学参数与临床反应相关的其他临床试验,以提供最佳的给药指导。药效学监测可以为传统药物水平测量提供替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号